Harris Todd 4
4 · Tyra Biosciences, Inc. · Filed Oct 22, 2024
Insider Transaction Report
Form 4
Harris Todd
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-10-21$28.16/sh−13,188$371,370→ 1,355,927 total - Sale
Common Stock
2024-10-18$27.01/sh−43,636$1,178,796→ 1,375,011 total - Sale
Common Stock
2024-10-21$27.32/sh−5,896$161,081→ 1,369,115 total
Footnotes (4)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.60 to $27.51. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.89 to $27.84. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $27.8957 to $28.5951. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.